$2.00 a share. MNKD + $30. a share, easy.
Cramer always brags that he recommonded REGN in the early days and printed money on it. He says stay away from MNKD though. I think he missed the boat on this one.
MNKD longs are the smartest in the stock market right now. We are in something that the whole investment world is going to want to wildly be in very shortly.
..always sell when these creeps say buy because the stock is top of the cycle and buy when they say sell as the the stock is near bottom of cycle. Good post, "we steal it"
Hey, in court they can't even prove cigarettes cause cancer! Nice try. Everyone owns Phillip Morris and others. Cash cows. MNKD will be one too unless buyout first.
..He says go into OPKO Health instead. This company has a market cap more than MNKD with not that much revenue. Just wait, when MNKD is going for $25.00 he will be pounding the table on it. But now? Hey he is biggest loser in the market.
The game is played downgrade at stocks bottom and upgrade at stocks top. GS put in mnkds bottom today. They are clueless like a fox. It is not real, don't sweat it.
and the world knows nothing about it yet! And the shorts continue to strangle the longs in this stock because of this very fact. They will continue to strangle until MNKD is finally found out.
why would EDSTROM HAKAN sell 30 per cent of his holdings recently if there was a buy out? He's been selling ever since he got on board. What does he know that we don't?
the treatment works at 24 hours, better standard of care than 6 hours. This will be the story Sunday and for next week.
great post i like your term "faithful basher". Shorts are not prepared for what lies ahead.
someone stay mega-short in a $5.00 stock like this? If it is just the soft launch and a timing thing, they must have a pipe to SNY insiders so as to know when to get out. Just guessing would be foolish. Why this extreme confidence?
..what if they take into Japan with current results and fast track it. This trial indicated major benefit up to 30 hours. Restrict it's use to that time frame and study it too.
"While the trial did not achieve the primary or component secondary endpoints, we believe the evidence indicating that patients who received MultiStem treatment early appeared to exhibit meaningfully better recovery is very important and promising," continued Dr. Van Bokkelen. "The results appear to confirm that our window of intervention with MultiStem therapy may extend well beyond the limits of current care. Additional key observations from the trial also appear consistent with key elements of our initial hypothesis. In particular, we are encouraged by the reduced mortality and lower incidence of infections, pulmonary events and life threatening adverse events among MultiStem-treated patients, as well as the limited biomarker data we have seen so far. We anticipate additional data and information from the study and will conduct further analyses to generate more insight about the potential for MultiStem treatment in this area."
yep, Al Mann is going to blow them up. Imagine in the instant when, Motley Fool, Cramer and all the shorts suddenly see they got it wrong big time.
..I am looking touch ten in the next 30 to 45 days.
Cramer was for MNKD and touted it seriously when Alfrezza was making initial rounds through the FDA and everyone who listened to him got pounded into the ground. Now he acts like he doesn't even know MNKD and this thing is ready for moon launch. MNKD will be the test case showing Cramer is clueless.